CommercialPrior AuthHigh impact
Hematopoietic Cell Transplantation for Non-Hodgkin Lymphomas
Blue Cross & Blue Shield of Mississippi·MS · Oncology, Hematology·Medical Policy
We identified it
Jun 20, 2026
Summary
Blue Cross Blue Shield of Mississippi has updated their policy for Hematopoietic Cell Transplantation for Non-Hodgkin Lymphomas, establishing specific medical necessity criteria for autologous and allogeneic HCT based on lymphoma subtype and treatment stage. All covered transplant procedures require prior authorization through Case Management.
Action Required
Immediately: Billing team must ensure all Hematopoietic Cell Transplantation procedures for Non-Hodgkin Lymphoma patients require prior authorization through Blue Cross Blue Shield of Mississippi Case Management before scheduling or billing. Update pre-authorization checklists and staff workflows to verify medical necessity criteria based on specific NHL subtype (aggressive B-cell, mantle cell, indolent B-cell, T-cell/NK cell, or hepatosplenic T-cell) and treatment stage. Claims will be denied without prior authorization.